Want to see TDOC full AI Analyst Report?
Teladoc (TDOC) Stock Price & Analysis
TDOC Stock Chart & Stats
- Day’s Range
- $8.75 - $9.45
- 52-Week Range
- $4.40 - $9.89
- Previous Close
- $9.41
- Volume
- N/A
- Average Volume (3M)
- 5.08M
- Market Cap
- $1.72B
- Enterprise Value
- $1.24B
- Total Cash (Recent Filing)
- $849.91M
- Total Debt (Recent Filing)
- $1.03B
- Price to Earnings (P/E)
- ―
- Beta
- 1.55
- Next Earnings
- Feb 23, 2027 (Est.)
- EPS Estimate
- -0.12
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Strong Cash Generation
Consistently positive operating and free cash flow gives Teladoc internal funding capacity for product investment, debt service, and strategic execution. The durable cash profile is especially important because it provides flexibility while the company works to convert improving operating performance into accounting profitability.
Improving Operating Efficiency
Higher EBITDA and expanding margins indicate that Teladoc is improving cost discipline and operating leverage despite a difficult revenue environment. If sustained, these gains can strengthen cash conversion, support reinvestment, and create a more durable earnings foundation across its platform.
Integrated Care Scale
Growth in Integrated Care revenue and clinic enrollment supports the durability of Teladoc’s broader care platform beyond individual virtual visits. Increasing adoption of bundled solutions and member engagement can deepen customer relationships and create opportunities to expand services over time.
Bears Say
Continued Net Losses
Persistent net losses show that improved EBITDA and cash generation have not yet translated into bottom-line profitability. Until the company closes that gap, returns on equity remain negative and management has less evidence that the current operating model can produce durable shareholder earnings.
BetterHelp Revenue Pressure
Sustained BetterHelp contraction remains a material drag on consolidated growth and reflects continuing weakness in the cash-pay market. Insurance expansion may provide a recovery path, but the transition brings lower margins and execution risk while the legacy revenue base continues to shrink.
Large Convertible Maturity
The upcoming $1 billion maturity is a significant capital-allocation obligation relative to the company’s operating cash flow. Addressing it may require available cash, new debt financing, or repayment at maturity, potentially limiting flexibility for investment and increasing refinancing exposure.
TDOC FAQ
What was Teladoc’s price range in the past 12 months?
What is Teladoc’s market cap?
When is Teladoc’s upcoming earnings report date?
How were Teladoc’s earnings last quarter?
Is Teladoc overvalued?
Does Teladoc pay dividends?
What is Teladoc’s EPS estimate?
How many shares outstanding does Teladoc have?
What happened to Teladoc’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Teladoc?
What is the TipRanks Smart Score and how is it calculated?
Teladoc Stock Smart Score
Company Description
Teladoc
Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Charles Divita
- Employees
- 5,124
- Website
- www.teladochealth.com
- Address
- 155 E 44th Street, New York, NY, 10017, US
Teladoc (TDOC) Earnings & Revenues
TDOC Company Deck
TDOC Earnings Call
Earnings Call SentimentPositive
The call was positive overall. Management reported a solid third quarter with adjusted EBITDA above guidance, expanding margins, strong cash flow and liquidity, improved leverage, Integrated Care growth, and accelerating BetterHelp insurance traction. These positives outweighed the ongoing BetterHelp cash pay decline, lower total revenue and paying users, margin pressure, and continued uncertainty around the business transition.
View all TDOC earnings summariesTDOC Net sales Breakdown
- 56.44% Teladoc Health Integrated Care
- 43.56% BetterHelp
TDOC Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 13 | 3 | 6 |
| Technical Analysis | 3 | 3 | 4 |
| Moving Averages | 10 | 0 | 2 |













